Popular Articles

SC refuses relief to Roche on patent plea against Cipla
The Supreme Court today refused to give any relief to Swiss pharma firm Hoffman La Roche Ltd that had challenged a Delhi High Court order allowing Cipla to manufacture and sell a generic version of lung cancer drug "Erlotinib".

Nifty likely to face resistance at 5,300
Investors were reluctant to buy or sell aggressively today ahead of a closely-watched US job report on Friday. The trading volume in Nifty futures and options (F&O) suggested mere change of hands as buy- and sell-side traders were evenly matched.

News of the day

6 of top 10 cos add Rs 24k cr in m-cap; Airtel biggest gainer
Six out of the top 10 companies added over Rs 24,000 crore to their market capitalisation last week with telecom giant Bharti Airtel alone contributing one-third of the gain.
Corporate

Infosys up 2% on growth outlook

The stock of Infosys Technologies rose nearly 2 per cent to close at Rs 2,235, a level not reached in over two years. - Infy remains cautious despite BP deal - K"taka clears first hurdle in Infy plan for 2nd campus - Slow US recovery to hit IT firms - Infy up 4 per cent on order from BP - Infosys bags 5 yrs outsourcing deal from BP - Infosys BPO partners US firm to provide mortgage solutions The stock, which has gained about 7 per cent over the last month, spurted after Nomura Holdings said it was changing its stance on the company from bearish to neutral. The stock touched an intra-day high of Rs 2,248 and a low of Rs 2,202.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):